Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanesa Pytel

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Journal of Alzheimer'S Disease : JAD|October 18, 2024
Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer's DiseaseXavier Morató, Juan Pablo Tartari, Vanesa Pytel, et al.
Journal of Alzheimer'S Disease : JAD|October 19, 2020
Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal DementiaJordi A Matias-Guiu, Vanesa Pytel, Jorge Matías-Guiu
International Journal of Molecular Sciences|August 26, 2022
Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer's Disease: Towards a Personalized Polypharmacology Patient-Centered ApproachXavier Morató, Vanesa Pytel, Sara Jofresa, et al.
Alzheimer Disease and Associated Disorders|February 1, 2024
Focusing on Earlier Management of Alzheimer Disease: Expert Opinion Based on a Modified Nominal Group TechniqueKristian Steen Frederiksen, Xavier Morató, Henrik Zetterberg, et al.
Multiple Sclerosis and Related Disorders|June 28, 2019
Differences in age of diagnosis in familial multiple sclerosisVanesa Pytel, Jordi A Matias-Guiu, Laura Torre-Fuentes, et al.
Multiple Sclerosis and Related Disorders|June 20, 2020
Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumabJorge Matías-Guiu, Paloma Montero-Escribano, Vanesa Pytel, et al.
Acta Neurologica Scandinavica|March 26, 2019
What is the meaning of PASAT rejection in multiple sclerosis?Ana Cortés-Martínez, Jordi A Matias-Guiu, Vanesa Pytel, et al.
Annals of Neurology|May 2, 2020
Amyloid Positron Emission Tomography in Multiple Sclerosis: Between Amyloid Deposition and Myelin DamageJordi A Matías-Guiu, María Nieves Cabrera-Martín, Vanesa Pytel, et al.
Multiple Sclerosis and Related Disorders|May 15, 2020
Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, SpainPaloma Montero-Escribano, Jorge Matías-Guiu, Patricia Gómez-Iglesias, et al.
Frontiers in Neuroscience|April 27, 2019
Notch Signalling in the Hippocampus of Patients With Motor Neuron DiseaseUlises Gómez-Pinedo, Lucía Galán, Jordi A Matías-Guiu, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Journal of Alzheimer'S Disease : JAD|October 18, 2024
Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer's DiseaseXavier Morató, Juan Pablo Tartari, Vanesa Pytel, et al.
Journal of Alzheimer'S Disease : JAD|October 19, 2020
Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal DementiaJordi A Matias-Guiu, Vanesa Pytel, Jorge Matías-Guiu
International Journal of Molecular Sciences|August 26, 2022
Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer's Disease: Towards a Personalized Polypharmacology Patient-Centered ApproachXavier Morató, Vanesa Pytel, Sara Jofresa, et al.
Alzheimer Disease and Associated Disorders|February 1, 2024
Focusing on Earlier Management of Alzheimer Disease: Expert Opinion Based on a Modified Nominal Group TechniqueKristian Steen Frederiksen, Xavier Morató, Henrik Zetterberg, et al.
Multiple Sclerosis and Related Disorders|June 28, 2019
Differences in age of diagnosis in familial multiple sclerosisVanesa Pytel, Jordi A Matias-Guiu, Laura Torre-Fuentes, et al.
Multiple Sclerosis and Related Disorders|June 20, 2020
Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumabJorge Matías-Guiu, Paloma Montero-Escribano, Vanesa Pytel, et al.
Acta Neurologica Scandinavica|March 26, 2019
What is the meaning of PASAT rejection in multiple sclerosis?Ana Cortés-Martínez, Jordi A Matias-Guiu, Vanesa Pytel, et al.
Annals of Neurology|May 2, 2020
Amyloid Positron Emission Tomography in Multiple Sclerosis: Between Amyloid Deposition and Myelin DamageJordi A Matías-Guiu, María Nieves Cabrera-Martín, Vanesa Pytel, et al.
Multiple Sclerosis and Related Disorders|May 15, 2020
Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, SpainPaloma Montero-Escribano, Jorge Matías-Guiu, Patricia Gómez-Iglesias, et al.
Frontiers in Neuroscience|April 27, 2019
Notch Signalling in the Hippocampus of Patients With Motor Neuron DiseaseUlises Gómez-Pinedo, Lucía Galán, Jordi A Matías-Guiu, et al.
Pageof 7